The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

MDGL FINANCIAL STATEMENTS

Madrigal Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

MDGLMadrigal Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-500 M0500 M1 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue1.3 B $Gross Profit1.2 B $ · 91%Operating Income-322.6 M $ · -25%Pre-tax Income-325.1 M $ · -25%Net Income to Owners-325.1 M $ · -25%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue1.3 B $+149.0%
Gross Profit1.2 B $+136.6%
Operating Income-322.6 M $—
EBITDA-298.8 M $—
Net Income to Owners-325.1 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets1.2 B
  • Equity523.7 M $42%
  • Current Liabilities374.2 M $30%
  • Long-term Liabilities346.7 M $28%

Key Figures

YoY change
Total Assets1.2 B $+22.6%
Total Liabilities720.9 M $+125.7%
Total Equity523.7 M $-24.7%
Cash & ST Investments838.8 M $+5.2%
Total Debt347.8 M $+180.6%
Net Debt55 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-400 M-200 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-200 M-100 M0100 M-197.7 M $Operating47 M $Investing251 M $Financing100.3 M $Net Change

Key Figures

YoY change
Operating Cash Flow-197.7 M $—
Capital Expenditures9.3 M $+859.9%
Free Cash Flow-206.3 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on MDGL

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.